title: Updated study on risk of cholestatic liver disease and flucloxacillin.
authors.forename: Lin
authors.initials: L
authors.lastname: Li
authors.forename: Hershel
authors.initials: H
authors.lastname: Jick
authors.forename: Susan S
authors.initials: SS
authors.lastname: Jick
mesh_terms: D002779:Cholestasis / Q000139:chemically induced*; D005436:Floxacillin / Q000009:adverse effects*; D006801:Humans; D012307:Risk Factors; D006113:United Kingdom
chemical_list: D005436:Floxacillin
references.citation: Emerg Infect Dis. 2008 May;14(5):720-6
references.pmid: 18439352
references.citation: Med J Aust. 1989 Dec 4-18;151(11-12):701-5
references.pmid: 2593915
references.citation: Med J Aust. 1994 Apr 18;160(8):525
references.pmid: 8170433
references.citation: Br J Clin Pharmacol. 2005 Jul;60(1):76-82
references.pmid: 15963097
references.citation: Soc Sci Med. 1999 Mar;48(6):845-53
references.pmid: 10190645
references.citation: Acta Med Scand. 1985;217(5):567-9
references.pmid: 4025011
references.citation: Scand J Infect Dis. 1985;17(1):125-8
references.pmid: 3992199
references.citation: Med J Aust. 1993 May 3;158(9):596-600
references.pmid: 8479374
references.citation: Clin Liver Dis. 2003 May;7(2):311-30
references.pmid: 12879986